TABLE 1.
Drug | Advantages | Disadvantages |
Evidence |
|||
---|---|---|---|---|---|---|
Type of study | n | Subjects | Findings | |||
Vagal blockade | ||||||
Atropine | Dose requirements known | Potential for CNS complications in overdose | RCT; atropine vs no therapy (12) | 30 | Term and preterm newborns | Prevention of bradycardia compared with no therapy |
Glycopyrrolate | Does not cross the blood-brain barrier | Uncertain dose requirements in the very preterm infant | RCT; given to both groups (16) | 20 | Term and preterm newborns | No bradycardia |
Analgesia/anesthesia | ||||||
Fentanyl | Potent opiate; PK data available (43) Good analgesic effect |
Dose requirements for intubation unknown in the newborn, rare occurrence of chest wall rigidity (44), unpredictable sedative effect (45) | Cohort study (40) Used in both arms of numerous small RCTs |
253 | Term and preterm newborns | Showed safety of a protocol including fentanyl and succinylcholine |
Alfentanil | Potent opiate | Dose requirements and kinetics unknown | RCT; in combination with succinylcholine vs meperidine without muscle relaxant (20) | 20 | Term and preterm newborns | Shorter intubation and reduced duration of hypoxia with alfentanil/succinylcholine |
Morphine | Opiate; PK data available Sedative effect |
Dose requirements unknown for this purpose, delayed onset of action limits efficacy for this purpose | RCT; morphine vs no premedication (21) | 60 | Term and preterm newborns | No effect on severity of physiological disturbance during intubation |
RCT; in combination with succinylcholine and atropine (17) vs nothing | 20 | Term and preterm newborns | Reduced time to intubate, (60 s vs 590 s), fewer attempts and less bradycardia | |||
Meperidine | Opiate with sedative effect | Causes nausea in older patients | RCT; meperidine vs alfentanil and succinylcholine (16) | 20 | Term and preterm newborns | More hypoxia than comparison group |
Remifentanil | Potent opiate Rapid acting, very rapid clearance and short duration of action, provides good levels of anesthesia |
May cause chest wall rigidity, hemodynamic effects uncertain in the newborn, limited PK data in the newborn | RCT; remifentanil vs morphine (48) | 20 | Preterm newborns | Improved intubating conditions with remifentanil |
Cohort study (49) | 21 | Preterm newborns 29 to 32 wks’ gestation | Good intubation conditions, rapid extubation | |||
RCT; remifentanil vs fentanyl plus succinylcholine (23) | 30 | Term and preterm newborns | Similar intubation conditions and complications, longer intubations and more chest wall rigidity with remifentanil alone, not statistically significant | |||
Methohexital | Barbiturate analogue Rapid acting, provides good levels of sedation |
Unfamiliar to many neonatologists, no PK data | Cohort study (27) | 18 | Newborns >32 wks’ gestation | Good sedation and intubating conditions |
Propofol | Very rapid acting, provides good levels of anesthesia | May cause hypotension, toxicity unknown in the newborn, little data on PK but reduced clearance in the newborn | Cohort study (50) | 100 | Newborns and infants 2.1 kg to 9.2 kg under halothane anesthesia | Short intubation time, excellent intubating conditions |
RCT; propofol vs morphine, succinylcholine and atropine (28) | 63 | Term and preterm newborns | Shorter intubation and less hypoxia with propofol | |||
Thiopental | Rapid-acting anesthetic agent | Causes hypotension in older children, prolonged and extremely variable clearance | RCT (25); thiopental vs no therapy | 30 | Newborn infants >2 kg | Blunts hypertensive response |
Muscle relaxation | ||||||
Pancuronium | Nondepolarizing agent, few side effects | Prolonged duration | RCT; atropine alone vs atropine plus pancuronium vs no therapy (12) | 30 | Term and preterm newborns | Smaller increase in intracranial pressure and less hypoxia during intubation |
Succinylcholine | Rapid acting, short duration of action | Depolarizing agent, rare serious complications, malignant hyperthermia, hyperkalemia, rhabdomyolysis | 4 RCTs (1 only partly randomized) (13,16–18) | 81 | Term and preterm newborns | Reduces intracranial pressure increase, shortens duration of the procedure, reduces number of attempts, reduces trauma |
Mivacurium | Nondepolarizing agent, few side effects, brief duration of action | Cohort study of use in combination with fentanyl and atropine (51) | 34 | Term and preterm newborns | Rapid onset (1–3 min), brief duration of action (5–15 min), very stable intubation conditions | |
RCT; mivacurium vs no mivacurium (all infants received fentanyl and atropine) (19) | 41 | Term and preterm newborns | Much shorter intubations and less hypoxemia with mivacurium | |||
Rocuronium | Nondepolarizing agent with rapid onset | Prolonged and variable duration (up to 1 h) | RCT; rocuronium vs no relaxant (all infants received fentanyl and atropine) (48) | 44 | Preterm newborns | Much more likely to be intubated on first attempt compared with controls |
CNS Central nervous system; PK Pharmacokinetic; RCT Randomized controlled trial; vs Versus; wks Weeks